WebCOMIRNATY® and the Pfizer-BioNTech COVID-19 vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series. Instructions for Each Formulation Inside. VIALS WITH PURPLE CAP/LABEL BORDER . For 12 years and older, DILUTE BEFORE USE formulation: pages 4–5 † VIALS WITH GRAY CAP/LABEL … WebAug 31, 2024 · Click for Fact Sheets and Prescribing Information for the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5): EUA Fact Sheet for Recipients and Caregivers (12 years of age and older) EUA Fact Sheet for Vaccination Providers (12 Years & Up), BIVALENT (Original and Omicron BA.4/BA.5), DO NOT …
COVID19 Temperature Excursion Report - Department of …
WebJul 8, 2024 · COVID-19 Vaccine Pfizer Pfizer (mRNA)(mRNA)¹: Maroon Cap Pfizer (mRNA)2: Orange Cap 3: Purple Cap Pfizer (mRNA)4: Gray Cap DO NOT DILUTE … WebJul 8, 2024 · COVID-19 Vaccine Pfizer Pfizer (mRNA)(mRNA)¹: Maroon Cap Pfizer (mRNA)2: Orange Cap 3: Purple Cap Pfizer (mRNA)4: Gray Cap DO NOT DILUTE Interval between booster #1 & booster #2 Not Eligible Not Eligible 4 months 4 months Dose Volume (booster #2) Not Eligible Not Eligible 0.3mL 0.3mL adells concert
Terms of Use Pfizer Medical Information - US
Web5 through 11 years of age: Orange cap and orange bordered label 12 years of age and older: » Purple cap and purple bordered label » Gray cap and gray bordered label Orange and purple cap formulations must be mixed BEFORE administering. Use 0.9% preservative-free normal saline diluent supplied in the ancillary supplies kit. WebComirnaty and Pfizer-BioNTech COVID-19 Vaccine are also authorized for emergency use to provide a third primary series dose to individuals 12 years of age and older with certain kinds of immunocompromise. The formulation for use as a primary series in individuals 12 years of age and older has a gray cap and label with a gray border. WebBivalent vaccines are not authorized for use as primary series in children < 12 years old. ≥ 12 Years. Pfizer-BioNTech Comirnaty® Original & Omicron BA.4/BA.5 30 mcg/0.3 mL (grey cap/grey border) Use for booster doses. These vaccines are not authorized to be used as a primary COVID-19 immunization series. jointex 2021 カタログ